New research has shown that RNA-based testing can improve the detection and interpretation of clinically actionable genomic alterations that lead to MET exon 14 skipping in patients with lung ...
ASCOLT's translational study found no survival benefit from aspirin in either prespecified subgroup: PIK3CA mutations or COX-2 overexpression. Pooling it with SAKK 41/13 and ALASCCA gave a 39% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results